The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

It is intended solely for informational purposes and does not constitute an offer, recommendation, endorsement, or any form of financial ... and tax advice. The Swiss franc briefly dipped after ...

Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not offer financial advice, advisory or brokerage services, nor do we ...